WallStreetZenWallStreetZen

NASDAQ: ONC
Beone Medicines Ltd Stock Ownership - Who owns Beone Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Beone Medicines Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John OylerChief Executive Officer2025-12-165,442$303.72
$1.65MSell
John OylerChief Executive Officer2025-12-161,255$304.13
$381.68kSell
John OylerChief Executive Officer2025-12-161,973$304.36
$600.51kSell
John OylerChief Executive Officer2025-12-1640$305.24
$12.21kSell
John OylerChief Executive Officer2025-12-161,633$303.13
$495.01kSell
John OylerChief Executive Officer2025-12-167,470$302.74
$2.26MSell
John OylerChief Executive Officer2025-12-161,512$302.31
$457.10kSell
John OylerChief Executive Officer2025-12-162,567$301.79
$774.70kSell
John OylerChief Executive Officer2025-12-16600$300.98
$180.59kSell
John OylerChief Executive Officer2025-12-161,877$300.80
$564.60kSell

1 of 29

ONC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ONC insiders and whales buy or sell their stock.

ONC Shareholders

What type of owners hold Beone Medicines Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hillhouse Capital Advisors Ltd10.22%147,035,258$45.14BInsider
Hhlr Advisors Ltd8.69%125,045,741$38.39BInsider
Hillhouse Capital Management Ltd7.71%110,866,146$34.04BInsider
Cb Biotech Investment Ltd1.36%19,601,138$6.02BInsider
Amgen Inc1.32%18,943,802$5.82BInsider
Baker Bros Advisors LP0.61%8,799,053$2.70BInstitution
Baker Bros Advisors LP0.56%8,078,829$2.48BInsider
Merck Co Inc0.55%7,942,314$2.44BInsider
Xiaodong Wang0.38%5,491,395$1.69BInsider
John Oyler0.36%5,243,229$1.61BInsider

1 of 3

ONC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONC2.29%32.02%Net BuyingNet Selling
INSM84.90%15.10%Net SellingNet Selling
RPRX56.76%17.33%Net SellingNet Selling
UTHR86.71%13.29%Net SellingNet Selling
BNTX20.98%0.00%
View Top Biotech Stocks

Beone Medicines Stock Ownership FAQ

Who owns Beone Medicines?

Beone Medicines (NASDAQ: ONC) is owned by 2.29% institutional shareholders, 32.02% Beone Medicines insiders, and 65.69% retail investors. Hillhouse Capital Advisors Ltd is the largest individual Beone Medicines shareholder, owning 147.04M shares representing 10.22% of the company. Hillhouse Capital Advisors Ltd's Beone Medicines shares are currently valued at $46.47B.

If you're new to stock investing, here's how to buy Beone Medicines stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.